133 related articles for article (PubMed ID: 31194859)
1. Bitter melon juice-intake modulates glucose metabolism and lactate efflux in tumors in its efficacy against pancreatic cancer.
Dhar D; Raina K; Kant R; Wempe MF; Serkova NJ; Agarwal C; Agarwal R
Carcinogenesis; 2019 Sep; 40(9):1164-1176. PubMed ID: 31194859
[TBL] [Abstract][Full Text] [Related]
2. Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells.
Dhar D; Deep G; Kumar S; Wempe MF; Raina K; Agarwal C; Agarwal R
Mol Carcinog; 2018 Sep; 57(9):1166-1180. PubMed ID: 29727019
[TBL] [Abstract][Full Text] [Related]
3. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
Dhar D; Raina K; Kumar D; Wempe MF; Bagby SM; Pitts TM; Orlicky DJ; Agarwal C; Messersmith WA; Agarwal R
Mol Carcinog; 2020 Oct; 59(10):1227-1240. PubMed ID: 32816368
[TBL] [Abstract][Full Text] [Related]
4. Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells.
Somasagara RR; Deep G; Shrotriya S; Patel M; Agarwal C; Agarwal R
Int J Oncol; 2015 Apr; 46(4):1849-57. PubMed ID: 25672620
[TBL] [Abstract][Full Text] [Related]
5. Comparative Pre-clinical Efficacy of Chinese and Indian Cultivars of Bitter Melon (
Kandhari K; Paudel S; Raina K; Agarwal C; Kant R; Wempe MF; O'Bryant C; Agarwal R
J Cancer Prev; 2021 Dec; 26(4):266-276. PubMed ID: 35047453
[TBL] [Abstract][Full Text] [Related]
6. Bitter melon juice activates cellular energy sensor AMP-activated protein kinase causing apoptotic death of human pancreatic carcinoma cells.
Kaur M; Deep G; Jain AK; Raina K; Agarwal C; Wempe MF; Agarwal R
Carcinogenesis; 2013 Jul; 34(7):1585-92. PubMed ID: 23475945
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome and metabolome changes induced by bitter melon (
Reed D; Kumar D; Kumar S; Raina K; Punia R; Kant R; Saba L; Cruickshank-Quinn C; Tabakoff B; Reisdorph N; Edwards MG; Wempe M; Agarwal C; Agarwal R
J Tradit Complement Med; 2022 May; 12(3):287-301. PubMed ID: 35493312
[TBL] [Abstract][Full Text] [Related]
8. GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.
Bernier M; Catazaro J; Singh NS; Wnorowski A; Boguszewska-Czubara A; Jozwiak K; Powers R; Wainer IW
Int J Cancer; 2017 Nov; 141(10):2131-2142. PubMed ID: 28741686
[TBL] [Abstract][Full Text] [Related]
9. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
Vaz CV; Marques R; Alves MG; Oliveira PF; Cavaco JE; Maia CJ; Socorro S
J Cancer Res Clin Oncol; 2016 Jan; 142(1):5-16. PubMed ID: 26048031
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Nambiar D; Prajapati V; Agarwal R; Singh RP
Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268
[TBL] [Abstract][Full Text] [Related]
11. Plasma anthocyanins and their metabolites reduce in vitro migration of pancreatic cancer cells, PANC-1, in a FAK- and NF-kB dependent manner: Results from the ATTACH-study a randomized, controlled, crossover trial in healthy subjects.
Mostafa H; Behrendt I; Meroño T; González-Domínguez R; Fasshauer M; Rudloff S; Andres-Lacueva C; Kuntz S
Biomed Pharmacother; 2023 Feb; 158():114076. PubMed ID: 36516693
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma.
Liu M; Quek LE; Sultani G; Turner N
Cancer Metab; 2016; 4():19. PubMed ID: 27777765
[TBL] [Abstract][Full Text] [Related]
13. Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models.
Ornelas A; McCullough CR; Lu Z; Zacharias NM; Kelderhouse LE; Gray J; Yang H; Engel BJ; Wang Y; Mao W; Sutton MN; Bhattacharya PK; Bast RC; Millward SW
BMC Cancer; 2016 Oct; 16(1):824. PubMed ID: 27784287
[TBL] [Abstract][Full Text] [Related]
14. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.
Sheng G; Gao Y; Wu H; Liu Y; Yang Y
J Orthop Surg Res; 2023 Feb; 18(1):131. PubMed ID: 36814318
[TBL] [Abstract][Full Text] [Related]
15. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer.
Dutta P; Perez MR; Lee J; Kang Y; Pratt M; Salzillo TC; Weygand J; Zacharias NM; Gammon ST; Koay EJ; Kim M; McAllister F; Sen S; Maitra A; Piwnica-Worms D; Fleming JB; Bhattacharya PK
J Proteome Res; 2019 Jul; 18(7):2826-2834. PubMed ID: 31120258
[TBL] [Abstract][Full Text] [Related]
16. Microsomal triglyceride transfer protein gene expression and ApoB secretion are inhibited by bitter melon in HepG2 cells.
Nerurkar PV; Pearson L; Efird JT; Adeli K; Theriault AG; Nerurkar VR
J Nutr; 2005 Apr; 135(4):702-6. PubMed ID: 15795421
[TBL] [Abstract][Full Text] [Related]
17. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
[TBL] [Abstract][Full Text] [Related]
18. Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions.
Nerurkar PV; Lee YK; Motosue M; Adeli K; Nerurkar VR
Br J Nutr; 2008 Oct; 100(4):751-9. PubMed ID: 18321395
[TBL] [Abstract][Full Text] [Related]
19. Autophagy inhibition improves the targeted radionuclide therapy efficacy of
Liu X; Li D; Ma T; Luo X; Peng Y; Wang T; Zuo C; Cai J
J Transl Med; 2024 Feb; 22(1):156. PubMed ID: 38360704
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
